Suzhou Fushilai Pharmaceutical Co. Ltd. Free Cash Flow Generation Index
Suzhou Fushilai Pharmaceutical Co. Ltd. free cash flow generation index. Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Free Cash Flow Generation Index of -1.24x as of December 2024. Free cash flow of CN¥-58.25 Million represents -1% of operating cash flow (CN¥47.07 Million). Check 301258 financial resilience to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Free cash flow generation index of Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024. Historical FCF Generation Index trend for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. Explore capital reinvestment ratio of Suzhou Fushilai Pharmaceutical Co. Ltd. to see what proportion of operating cash flow is directed to capital expenditures.
Suzhou Fushilai Pharmaceutical Co. Ltd. Free Cash Flow Generation Index by Year (2019–2024)
Suzhou Fushilai Pharmaceutical Co. Ltd. free cash flow generation index by year from 2019 to 2024. Year-by-year Free Cash Flow Generation Index for Suzhou Fushilai Pharmaceutical Co. Ltd.. For the full cash flow conversion analysis, see Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) cash conversion ratio.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.24x | CN¥-58.25 Million | CN¥47.07 Million | CN¥105.31 Million | ▼ -320.7% |
| 2023 | 0.56x | CN¥53.15 Million | CN¥94.77 Million | CN¥41.62 Million | ▼ -16.1% |
| 2022 | 0.67x | CN¥101.08 Million | CN¥151.19 Million | CN¥50.11 Million | ▲ +12.2% |
| 2021 | 0.60x | CN¥118.98 Million | CN¥199.73 Million | CN¥80.75 Million | ▼ -1.7% |
| 2020 | 0.61x | CN¥101.16 Million | CN¥166.85 Million | CN¥65.69 Million | ▲ +14.6% |
| 2019 | 0.53x | CN¥79.62 Million | CN¥150.55 Million | CN¥70.93 Million | — |